The five principles that make up the hypothesis of columnar organization for somatosensory cerebral cortex are considered in relation to their experimental foundations. Several important implications that flow from these principles are examined, and the requirements for their experimental evaluation are elaborated. A number of specific measurements are found to be lacking in necessary precision: the total amount of somatosensory cerebral tissue in each area, the sizes, shapes and degree of overlap of aggregate excitatory receptive fields, the number of distinct modalities and the modality equivalences in our different linguistic categories, the sizes and shapes of the columns and, finally, the number of columns for each modality and the total number of columns. Some possible columnar arrangements are set up, and their experimental detectability is assessed, using optimal conditions and values. It is shown that if a columnar structure exists, it defies clear detection by current neurophysiological techniques and experimental approaches. The concept of an ''elementary functional unit'' is found to need clear definition; taken at face value, it is shown to yield some rather unusual predictions. The conditions under which the hypothesis of columnar organization can be distinguished from its rival, the hypothesis of topographic organization, are also reviewed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.